Woodline Partners’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-409,333
Closed -$4.34M 565
2024
Q1
$4.34M Buy
+409,333
New +$3.58M 0.04% 374
2023
Q4
Sell
-496,566
Closed -$4.08M 496
2023
Q3
$4.08M Buy
+496,566
New +$4.28M 0.05% 337
2023
Q1
Sell
-1,349,572
Closed -$8.48M 638
2022
Q4
$8.48M Sell
1,349,572
-1
-0% -$7 0.11% 238
2022
Q3
$9.3M Hold
1,349,573
0.13% 207
2022
Q2
$11.3M Buy
1,349,573
+336,111
+33% +$4.7M 0.17% 162
2022
Q1
$23.2M Buy
1,013,462
+10,944
+1% +$268K 0.38% 75
2021
Q4
$27.7M Sell
1,002,518
-237,240
-19% -$6.35M 0.4% 56
2021
Q3
$34.5M Buy
1,239,758
+996,544
+410% +$28.3M 0.56% 41
2021
Q2
$7.13M Buy
+243,214
New +$7.37M 0.13% 181

Other funds holding BHC

Woodline Partners's BHC Position: Q2 2024 in Review

Woodline Partners sold out of Bausch Health (BHC) in Q2 2024, closing a stake of 409,333 shares — an estimated $4.34M sold.

Woodline Partners first reported a position in BHC in Q2 2021 and held it in 9 quarters. The position peaked at $34.5M in Q3 2021. 234 funds tracked by Wall St. Rank hold BHC as of Q2 2024.

  • Woodline Partners reported no remaining Bausch Health position as of Q2 2024 after selling out during the quarter.
  • Woodline Partners sold 409,333 Bausch Health shares in Q2 2024, an estimated $4.34M.
  • Woodline Partners first reported a position in Bausch Health in Q2 2021 and held it in 9 quarters.
  • Woodline Partners's Bausch Health position peaked at $34.5M in Q3 2021.
  • 234 funds tracked by Wall St. Rank held Bausch Health as of Q2 2024.

Based on Woodline Partners's 13F filing for Q2 2024, filed 14 Aug 2024.